MANE Collar Strategy
MANE (Veradermics, Incorporated), in the Healthcare sector, (Biotechnology industry), listed on NYSE.
Veradermics, Incorporated functions as a biopharmaceutical enterprise focused on devising pioneering therapeutic interventions for various skin and cosmetic disorders. The company's development pipeline includes treatments for Pattern Hair Loss (PHL), impacting both adult and pediatric demographics. A flagship offering is VDPHL01, an orally administered, non-hormonal medication specifically for chronic hair loss management in both male and female patients with PHL. Furthermore, Veradermics is progressing with VDMN, an innovative dissolvable microarray patch technology employing immunotherapy for common warts. Its research also extends to VDAA for addressing alopecia areata, and VDMC, aimed at molluscum contagiosum. Collectively, the firm's product candidates target conditions such as androgenetic alopecia, common warts, molluscum contagiosum, alopecia areata, and atopic dermatitis.
MANE (Veradermics, Incorporated) trades in the Healthcare sector, specifically Biotechnology, with a market capitalization of approximately $4.56B, a beta of 1.35 versus the broader market, a 52-week range of 32-131.24, average daily share volume of 689K, a public-listing history dating back to 2026, approximately 24 full-time employees. These structural characteristics shape how MANE stock options price implied volatility around earnings windows, capital events, and macro-driven sector rotations.
A beta of 1.35 indicates MANE has historically moved more than the broader market, amplifying both the directional payoff and the realized volatility relative to an index-equivalent position.
What is a collar on MANE?
A collar pairs long stock with a protective out-of-the-money put financed by a short out-of-the-money call, capping both tails of the position around the current spot.
MANE snapshot
As of August 14, 2026, spot at $111.50, ATM IV 100.80%, expected move 28.90%. The collar on MANE below is built from the August 14, 2026 end-of-day chain, with strikes snapped to listed contracts and premiums pulled from the bid/ask midpoint at a 35-day expiry.
Why this collar structure on MANE specifically: IV rank is unavailable in the current snapshot, so regime-based timing for MANE is inferred from ATM IV at 100.80% alone, with a market-implied 1-standard-deviation move of approximately 28.90% (roughly $32.22 on the underlying). The 35-day window matched to the front-month expiry keeps theta exposure bounded while still capturing the post-snapshot move; longer-dated MANE expiries trade a higher absolute premium for lower per-day decay. Position sizing on MANE should anchor to the underlying notional of $111.50 per share and to the trader's directional view on MANE stock.
MANE collar setup
The MANE collar below is built from the August 14, 2026 end-of-day chain, with each option leg priced at the bid/ask midpoint of its listed strike. With MANE at $111.50 on that close, the first option leg uses a $115.00 strike; additional legs (when the strategy has them) anchor to spot-relative offsets. Premiums come from the bid/ask midpoint on the listed MANE chain at a 35-day expiry; the cross-strike IV skew is reflected directly in the per-leg values rather than approximated. Quantity sizing assumes one contract per option leg (or 100 MANE shares for the stock leg in covered calls and collars).
| Action | Type | Strike / Basis | Premium (est) |
|---|---|---|---|
| Buy 100 shares | Stock | $111.50 | long |
| Sell 1 | Call | $115.00 | $12.40 |
| Buy 1 | Put | $105.00 | $10.40 |
MANE collar risk and reward
- Net Premium / Debit
- -$10,950.00
- Max Profit (per contract)
- $550.00
- Max Loss (per contract)
- -$450.00
- Breakeven(s)
- $109.50
- Risk / Reward Ratio
- 1.222
Max profit roughly equals short-call strike minus cost basis plus net premium; max loss roughly equals cost basis minus long-put strike minus net premium. Breakeven shifts by the net premium.
MANE collar payoff curve
Modeled P&L at expiration across a range of underlying prices for the collar on MANE. Each row is one sampled price point from the computed payoff curve; the full curve uses 200 price points internally before being summarized into 10 rows here.
| Underlying Price | % From Spot | P&L at Expiration |
|---|---|---|
| $0.01 | -100.0% | -$450.00 |
| $24.66 | -77.9% | -$450.00 |
| $49.31 | -55.8% | -$450.00 |
| $73.97 | -33.7% | -$450.00 |
| $98.62 | -11.6% | -$450.00 |
| $123.27 | +10.6% | +$550.00 |
| $147.92 | +32.7% | +$550.00 |
| $172.58 | +54.8% | +$550.00 |
| $197.23 | +76.9% | +$550.00 |
| $221.88 | +99.0% | +$550.00 |
When traders use collar on MANE
Collars on MANE hedge an existing long MANE stock position; the long put sets a floor while the short call finances it, often run as a near-zero-cost hedge during expected volatility windows.
MANE thesis for this collar
The market-implied 1-standard-deviation range for MANE extends from approximately $79.28 on the downside to $143.72 on the upside. A MANE collar hedges an existing long MANE position with a protective put while financing the put cost via a short call; when the premiums roughly offset, the collar acts as a near-zero-cost insurance band around the current spot. As a Healthcare name, MANE options can move on sector-level news flow (peer earnings, regulatory updates, industry-specific macro data) in addition to MANE-specific events.
MANE collar positions are structurally neutral (protective); the modeled P&L assumes European-style exercise at expiration and ignores early assignment, transaction costs, dividends paid before expiry on the stock leg (when present), and the bid-ask spread on the listed chain. MANE positions also carry Healthcare sector concentration risk; news flow inside the sector (peer earnings, regulatory shifts, supply-chain headlines) can move MANE alongside the broader basket even when MANE-specific fundamentals are unchanged. Always rebuild the position from current MANE chain quotes before placing a trade.
Frequently asked questions
- What is a collar on MANE?
- A collar on MANE is the collar strategy applied to MANE (stock). The strategy is structurally neutral (protective): A collar pairs long stock with a protective out-of-the-money put financed by a short out-of-the-money call, capping both tails of the position around the current spot. With MANE stock at $111.50 on the August 14, 2026 close, the strikes shown on this page are snapped to the nearest listed MANE chain strike and the premiums come straight from that session's bid/ask midpoint.
- How are MANE collar max profit and max loss calculated?
- Max profit roughly equals short-call strike minus cost basis plus net premium; max loss roughly equals cost basis minus long-put strike minus net premium. Breakeven shifts by the net premium. For the MANE collar priced from the August 14, 2026 end-of-day chain at a 30-day expiry (ATM IV 100.80%), the computed maximum profit is $550.00 per contract and the computed maximum loss is -$450.00 per contract. Live intraday quotes will differ as the chain moves through the trading session.
- What is the breakeven for a MANE collar?
- The breakeven for the MANE collar priced on this page is roughly $109.50 at expiration, derived from the August 14, 2026 end-of-day chain's premiums. Breakeven is the underlying price at which the strategy's P&L crosses zero ignoring transaction costs and assignment risk. The MANE market-implied 1-standard-deviation expected move in the same options snapshot is approximately 28.90%; if the move sits well outside the breakeven distance, the structure's risk-reward becomes correspondingly tighter.
- When should you consider a collar on MANE?
- Collars on MANE hedge an existing long MANE stock position; the long put sets a floor while the short call finances it, often run as a near-zero-cost hedge during expected volatility windows.
- How does current MANE implied volatility affect this collar?
- Current MANE ATM IV is 100.80%; IV rank context is unavailable in the current snapshot.